chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Teenage patient who inadvertently received one dose of Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Teenage patient who inadvertently received one dose of Moderna COVID-19 vaccine) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Teenage patient who inadvertently received one dose of Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Teenage patient who inadvertently received one dose of Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment was not reported.   Patient received Moderna Vaccine and per source document the patient will meet the age criteria for the Pfizer-BioNTech COVID-19 vaccine and wanted to know how long to wait before receiving the Pfizer Vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second vaccination given on day 21; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second vaccination given on day 21) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second vaccination given on day 21). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second vaccination given on day 21) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Bone pain, Chills, Diarrhoea, Feeling hot
Clinical narrative: headache; Fever; Pain in the bones; Hotness; Stomachache; diarrhea; Flu-like symptoms; Malaise; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pain in the bones), FEELING HOT (Hotness), ABDOMINAL PAIN UPPER (Stomachache), DIARRHOEA (diarrhea) and INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Malaise) and CHILLS (Chills). On 15-May-2021, the patient experienced BONE PAIN (Pain in the bones), FEELING HOT (Hotness), ABDOMINAL PAIN UPPER (Stomachache), DIARRHOEA (diarrhea) and PYREXIA (Fever). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at an unspecified dose and frequency. On 14-May-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Malaise) and CHILLS (Chills) had resolved. At the time of the report, BONE PAIN (Pain in the bones), FEELING HOT (Hotness), ABDOMINAL PAIN UPPER (Stomachache), DIARRHOEA (diarrhea), PYREXIA (Fever) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not take any concomitant medications. Action taken with mRNA-1273 in response to the events is not applicable
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Malaise, Pyrexia
Clinical narrative: headache; Fever; Pain in the bones; Hotness; Stomachache; diarrhea; Flu-like symptoms; Malaise; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pain in the bones), FEELING HOT (Hotness), ABDOMINAL PAIN UPPER (Stomachache), DIARRHOEA (diarrhea) and INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Malaise) and CHILLS (Chills). On 15-May-2021, the patient experienced BONE PAIN (Pain in the bones), FEELING HOT (Hotness), ABDOMINAL PAIN UPPER (Stomachache), DIARRHOEA (diarrhea) and PYREXIA (Fever). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at an unspecified dose and frequency. On 14-May-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms), MALAISE (Malaise) and CHILLS (Chills) had resolved. At the time of the report, BONE PAIN (Pain in the bones), FEELING HOT (Hotness), ABDOMINAL PAIN UPPER (Stomachache), DIARRHOEA (diarrhea), PYREXIA (Fever) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not take any concomitant medications. Action taken with mRNA-1273 in response to the events is not applicable
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Myalgia
Clinical narrative: arm pain; chills; tiredness; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (arm pain), CHILLS (chills) and FATIGUE (tiredness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced MYALGIA (arm pain), CHILLS (chills) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of PO BID for 5 days and IBUPROFEN at a dose of 800 mg as required. At the time of the report, MYALGIA (arm pain), CHILLS (chills) and FATIGUE (tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, COVID-19: positive.         This case was linked to MOD-2021-154871 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Insomnia, Myalgia, Pain
Clinical narrative: She couldn't sleep all night.; Same day after receiving 2nd dose, she started having pain in whole body; She also started with headache; fever; chills; it is way too much pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (it is way too much pain), INSOMNIA (She couldn't sleep all night.), MYALGIA (Same day after receiving 2nd dose, she started having pain in whole body), HEADACHE (She also started with headache) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included COLECALCIFEROL (VITAMIN D3) for an unknown indication.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (it is way too much pain). On 19-May-2021, the patient experienced INSOMNIA (She couldn't sleep all night.), MYALGIA (Same day after receiving 2nd dose, she started having pain in whole body), HEADACHE (She also started with headache), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (it is way too much pain), INSOMNIA (She couldn't sleep all night.), MYALGIA (Same day after receiving 2nd dose, she started having pain in whole body), HEADACHE (She also started with headache), PYREXIA (fever) and CHILLS (chills) had not resolved.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: She couldn't sleep all night.; Same day after receiving 2nd dose, she started having pain in whole body; She also started with headache; fever; chills; it is way too much pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (it is way too much pain), INSOMNIA (She couldn't sleep all night.), MYALGIA (Same day after receiving 2nd dose, she started having pain in whole body), HEADACHE (She also started with headache) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included COLECALCIFEROL (VITAMIN D3) for an unknown indication.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (it is way too much pain). On 19-May-2021, the patient experienced INSOMNIA (She couldn't sleep all night.), MYALGIA (Same day after receiving 2nd dose, she started having pain in whole body), HEADACHE (She also started with headache), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (it is way too much pain), INSOMNIA (She couldn't sleep all night.), MYALGIA (Same day after receiving 2nd dose, she started having pain in whole body), HEADACHE (She also started with headache), PYREXIA (fever) and CHILLS (chills) had not resolved.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Tenderness
Clinical narrative: bruising; tenderness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 21-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of CONTUSION (bruising) and TENDERNESS (tenderness) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONTUSION (bruising) and TENDERNESS (tenderness). At the time of the report, CONTUSION (bruising) and TENDERNESS (tenderness) outcome was unknown.            Concomitant product includes cholesterol medication. No treatment was reported. Action taken in response to mRNA-1273 was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Hot flush, Malaise, Nausea
Clinical narrative: feel really sick on same day; little tired from work; Nausea; Vomiting; Hot flash; Fever of 101.5 degrees Fahrenheit; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (Hot flash), PYREXIA (Fever of 101.5 degrees Fahrenheit), NAUSEA (Nausea), VOMITING (Vomiting) and MALAISE (feel really sick on same day) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO INFORMATION WAS ADDED.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced HOT FLUSH (Hot flash) and PYREXIA (Fever of 101.5 degrees Fahrenheit). On 20-May-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). On an unknown date, the patient experienced MALAISE (feel really sick on same day) and FATIGUE (little tired from work). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 20-May-2021, HOT FLUSH (Hot flash) and PYREXIA (Fever of 101.5 degrees Fahrenheit) had resolved. On 21-May-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, MALAISE (feel really sick on same day) and FATIGUE (little tired from work) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   NO CONCOMITANT AND TREATMENT MEDICATION WERE USED   This case was linked to MOD-2021-162407 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: feel really sick on same day; little tired from work; Nausea; Vomiting; Hot flash; Fever of 101.5 degrees Fahrenheit; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (Hot flash), PYREXIA (Fever of 101.5 degrees Fahrenheit), NAUSEA (Nausea), VOMITING (Vomiting) and MALAISE (feel really sick on same day) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO INFORMATION WAS ADDED.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced HOT FLUSH (Hot flash) and PYREXIA (Fever of 101.5 degrees Fahrenheit). On 20-May-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). On an unknown date, the patient experienced MALAISE (feel really sick on same day) and FATIGUE (little tired from work). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 20-May-2021, HOT FLUSH (Hot flash) and PYREXIA (Fever of 101.5 degrees Fahrenheit) had resolved. On 21-May-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, MALAISE (feel really sick on same day) and FATIGUE (little tired from work) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   NO CONCOMITANT AND TREATMENT MEDICATION WERE USED   This case was linked to MOD-2021-162407 (Patient Link).
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Illness, Pain
Clinical narrative: First shot I was very sick; just felt yukky; Achy; tired; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (First shot I was very sick), FEELING ABNORMAL (just felt yukky), PAIN (Achy) and FATIGUE (tired) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (First shot I was very sick), FEELING ABNORMAL (just felt yukky), PAIN (Achy) and FATIGUE (tired). At the time of the report, ILLNESS (First shot I was very sick), FEELING ABNORMAL (just felt yukky), PAIN (Achy) and FATIGUE (tired) outcome was unknown.            This case was linked to MOD-2021-162385 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-162385:2nd dose case
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Illness, Myalgia, Rhinorrhoea
Clinical narrative: was sick for two weeks; body aches; really bad cough; Runny nose; headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (was sick for two weeks), MYALGIA (body aches), COUGH (really bad cough), RHINORRHOEA (Runny nose) and HEADACHE (headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (was sick for two weeks), MYALGIA (body aches), COUGH (really bad cough), RHINORRHOEA (Runny nose) and HEADACHE (headache). At the time of the report, ILLNESS (was sick for two weeks), MYALGIA (body aches), COUGH (really bad cough), RHINORRHOEA (Runny nose) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: given Johnson and Johnson Covid 19 vaccine after being given 2 doses of the Moderna Covid-19; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (given Johnson and Johnson Covid 19 vaccine after being given 2 doses of the Moderna Covid-19) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hepatitis in February 2017. Concurrent medical conditions included Hypertension, Asthma and Tachycardia. Concomitant products included LEVALBUTEROL [LEVOSALBUTAMOL] for Asthma, HYDROCHLOROTHIAZIDE for Hypertension.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (given Johnson and Johnson Covid 19 vaccine after being given 2 doses of the Moderna Covid-19). On 20-May-2021, INCORRECT DOSE ADMINISTERED (given Johnson and Johnson Covid 19 vaccine after being given 2 doses of the Moderna Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: follow up received: Patient demographics, medical history and concomitants were added.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Vaccination complication
Clinical narrative: so sick; BP has been elevated; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (so sick), HYPERTENSION (BP has been elevated) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (so sick), HYPERTENSION (BP has been elevated) and HEADACHE (headache). At the time of the report, VACCINATION COMPLICATION (so sick), HYPERTENSION (BP has been elevated) and HEADACHE (headache) had not resolved.            No concomitant and treatment information were reported.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 101.5; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101.5) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced PYREXIA (fever of 101.5). At the time of the report, PYREXIA (fever of 101.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-May-2021, Body temperature: 101.5 (High) Fever.         Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna COVID-19 vaccine administered to a patient under 18 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old). On 09-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not provided  Treatment medication were not provided
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Diarrhoea, Headache, Myalgia
Clinical narrative: pain in tooth; pain in jaw; diarrhea; pain in the feet/hands; painful headache; muscle aches; vomiting; joint pain; fever of 102.4; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (pain in tooth), PAIN IN JAW (pain in jaw), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (pain in the feet/hands) and HEADACHE (painful headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced TOOTHACHE (pain in tooth), PAIN IN JAW (pain in jaw), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (pain in the feet/hands), HEADACHE (painful headache), MYALGIA (muscle aches), VOMITING (vomiting), ARTHRALGIA (joint pain) and PYREXIA (fever of 102.4). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, TOOTHACHE (pain in tooth), PAIN IN JAW (pain in jaw), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (pain in the feet/hands), HEADACHE (painful headache), MYALGIA (muscle aches), VOMITING (vomiting), ARTHRALGIA (joint pain) and PYREXIA (fever of 102.4) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-May-2021, Body temperature: 102.4 (High) 102.4.         Non-pharmacological treatment included use of ice pack.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pain in jaw, Pyrexia, Toothache, Vomiting
Clinical narrative: pain in tooth; pain in jaw; diarrhea; pain in the feet/hands; painful headache; muscle aches; vomiting; joint pain; fever of 102.4; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (pain in tooth), PAIN IN JAW (pain in jaw), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (pain in the feet/hands) and HEADACHE (painful headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced TOOTHACHE (pain in tooth), PAIN IN JAW (pain in jaw), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (pain in the feet/hands), HEADACHE (painful headache), MYALGIA (muscle aches), VOMITING (vomiting), ARTHRALGIA (joint pain) and PYREXIA (fever of 102.4). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, TOOTHACHE (pain in tooth), PAIN IN JAW (pain in jaw), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (pain in the feet/hands), HEADACHE (painful headache), MYALGIA (muscle aches), VOMITING (vomiting), ARTHRALGIA (joint pain) and PYREXIA (fever of 102.4) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-May-2021, Body temperature: 102.4 (High) 102.4.         Non-pharmacological treatment included use of ice pack.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: feel side effects so long; still not feeling completely well; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (still not feeling completely well) and VACCINATION COMPLICATION (feel side effects so long) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2021, the patient experienced VACCINATION COMPLICATION (still not feeling completely well). On an unknown date, the patient experienced VACCINATION COMPLICATION (feel side effects so long). At the time of the report, VACCINATION COMPLICATION (still not feeling completely well) and VACCINATION COMPLICATION (feel side effects so long) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       NO CONCOMITANT AND TREATMENT MEDICATION WERE USED   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Blister, Chills, Headache, Myalgia, Nausea
Clinical narrative: day blisters on mouth; night sweats; vomiting; shakes; headache; muscle aches; nausea; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (day blisters on mouth), NIGHT SWEATS (night sweats), VOMITING (vomiting), TREMOR (shakes) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced VOMITING (vomiting), TREMOR (shakes), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea) and CHILLS (chills). On 22-May-2021, the patient experienced BLISTER (day blisters on mouth) and NIGHT SWEATS (night sweats). At the time of the report, BLISTER (day blisters on mouth), NIGHT SWEATS (night sweats), VOMITING (vomiting), TREMOR (shakes), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant or treatment medications were reported.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Night sweats, Tremor, Vomiting
Clinical narrative: day blisters on mouth; night sweats; vomiting; shakes; headache; muscle aches; nausea; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (day blisters on mouth), NIGHT SWEATS (night sweats), VOMITING (vomiting), TREMOR (shakes) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced VOMITING (vomiting), TREMOR (shakes), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea) and CHILLS (chills). On 22-May-2021, the patient experienced BLISTER (day blisters on mouth) and NIGHT SWEATS (night sweats). At the time of the report, BLISTER (day blisters on mouth), NIGHT SWEATS (night sweats), VOMITING (vomiting), TREMOR (shakes), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant or treatment medications were reported.    Reporter did not allow further contact
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Product administered to patient of inappropriate age, Vaccination site pain
Clinical narrative: sore arm at the injection site after the first dose; headache after the first dose; Moderna COVID-19 vaccine administered to a patient under 18 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old), VACCINATION SITE PAIN (sore arm at the injection site after the first dose) and HEADACHE (headache after the first dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm at the injection site after the first dose) and HEADACHE (headache after the first dose). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. On 09-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm at the injection site after the first dose) and HEADACHE (headache after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The nurse reported  patient under the age of 18 years old receiving the first dose of Moderna COVID-19 vaccine on 9Apr2021 and the second dose of Moderna COVOD-19 vaccine on 7May2021. Nurse stated the patient complained of sore arm at the injection site and  headache after the first dose.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna COVID-19 vaccine administered to patient under 18 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to patient under 18 years old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to patient under 18 years old). On 09-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to patient under 18 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs provided.  No treatment drugs provided.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VOMITING (vomiting). At the time of the report, VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   NO INVALID PATIENT IDENTIFIER   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: a paient did not get their second dose of moderna as schedules; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (a paient did not get their second dose of moderna as schedules) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (a paient did not get their second dose of moderna as schedules). At the time of the report, PRODUCT DOSE OMISSION ISSUE (a paient did not get their second dose of moderna as schedules) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Is shortness of breath common after second dose of moderna vaccine?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Is shortness of breath common after second dose of moderna vaccine?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Is shortness of breath common after second dose of moderna vaccine?). At the time of the report, DYSPNOEA (Is shortness of breath common after second dose of moderna vaccine?) outcome was unknown. Not Provided          no concomitant medication were reported no treatment information was provided
Sex: U
Vaccine: COVID19
Symptoms: Haematuria
Clinical narrative: Hematuria/blood in my urine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HAEMATURIA (Hematuria/blood in my urine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HAEMATURIA (Hematuria/blood in my urine). At the time of the report, HAEMATURIA (Hematuria/blood in my urine) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Mobility decreased, Vaccination complication
Clinical narrative: Had bad side effects; Couldn't move my next; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had bad side effects) and MOBILITY DECREASED (Couldn't move my next) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had bad side effects) and MOBILITY DECREASED (Couldn't move my next). At the time of the report, VACCINATION COMPLICATION (Had bad side effects) and MOBILITY DECREASED (Couldn't move my next) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Vaccination complication
Clinical narrative: typical vaccine side effects; burning sensation in my internal organs; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation in my internal organs) and VACCINATION COMPLICATION (typical vaccine side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced BURNING SENSATION (burning sensation in my internal organs). On an unknown date, the patient experienced VACCINATION COMPLICATION (typical vaccine side effects). At the time of the report, BURNING SENSATION (burning sensation in my internal organs) and VACCINATION COMPLICATION (typical vaccine side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not reported.  Treatment details was not reported .
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Lymphadenopathy, Vomiting
Clinical narrative: Swollen glades; Vomiting; Low energy; This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (Swollen glades), VOMITING (Vomiting) and ASTHENIA (Low energy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced LYMPHADENOPATHY (Swollen glades), VOMITING (Vomiting) and ASTHENIA (Low energy). At the time of the report, LYMPHADENOPATHY (Swollen glades), VOMITING (Vomiting) and ASTHENIA (Low energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided . No treatment details were provided.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting normal following the 2nd Covid vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting normal following the 2nd Covid vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (vomiting normal following the 2nd Covid vaccine). At the time of the report, VOMITING (vomiting normal following the 2nd Covid vaccine) outcome was unknown.            No concomitant medication was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site mass
Clinical narrative: Hard lump at my vaccination site; Hardness at vaccination site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard lump at my vaccination site) and VACCINATION SITE INDURATION (Hardness at vaccination site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 mg. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Hard lump at my vaccination site) and VACCINATION SITE INDURATION (Hardness at vaccination site). At the time of the report, VACCINATION SITE MASS (Hard lump at my vaccination site) and VACCINATION SITE INDURATION (Hardness at vaccination site) outcome was unknown.            NO CONCOMITANT AND TREATMENT MEDICATION WERE ADDED
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstrual disorder, Muscle spasms, Pain in extremity
Clinical narrative: Heavy Menstrual Bleeding; Has not had her Period since 2018,Within hours after the first shot she had her Period; Muscle spasms; Sore Left Arm; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Heavy Menstrual Bleeding), MENSTRUAL DISORDER (Has not had her Period since 2018,Within hours after the first shot she had her Period), MUSCLE SPASMS (Muscle spasms) and PAIN IN EXTREMITY (Sore Left Arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (Heavy Menstrual Bleeding), MENSTRUAL DISORDER (Has not had her Period since 2018,Within hours after the first shot she had her Period), MUSCLE SPASMS (Muscle spasms) and PAIN IN EXTREMITY (Sore Left Arm). On 18-Apr-2021, HEAVY MENSTRUAL BLEEDING (Heavy Menstrual Bleeding), MENSTRUAL DISORDER (Has not had her Period since 2018,Within hours after the first shot she had her Period), MUSCLE SPASMS (Muscle spasms) and PAIN IN EXTREMITY (Sore Left Arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided Treatment information was not provided Patient stated that she didn't have a period since 2018   This case was linked to MOD-2021-163948 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Dry mouth, Thirst
Clinical narrative: Dry mouth; Always thirsty; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth) and THIRST (Always thirsty) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported. No concomitant medication reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (Dry mouth) and THIRST (Always thirsty). At the time of the report, DRY MOUTH (Dry mouth) and THIRST (Always thirsty) outcome was unknown.            No Concomitant medications was provided by the reporter.  No Treatment medications was provided by the reporter.